# Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Study · id `cardio:ct-nct03715998` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03715998](<https://clinicaltrials.gov/study/NCT03715998>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03715998

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.

## Technical summary

Registry record NCT03715998. Randomized; quadruple masking; primary purpose treatment. Start 2019-06-04 (actual); primary completion 2021-07-08 (actual). Results posted on 2023-02-27.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 295 participants (enrolled count; ClinicalTrials.gov record NCT03715998, source copy `cardio:ctgov-nct03715998-2023-02-27`, retrieved 2026-10-26)
- Started: 2019-06-04 (actual) (ClinicalTrials.gov record NCT03715998, source copy `cardio:ctgov-nct03715998-2023-02-27`, retrieved 2026-10-26)
- Primary completion: 2021-07-08 (actual) (ClinicalTrials.gov record NCT03715998, source copy `cardio:ctgov-nct03715998-2023-02-27`, retrieved 2026-10-26)
- Completion: 2021-07-08 (actual) (ClinicalTrials.gov record NCT03715998, source copy `cardio:ctgov-nct03715998-2023-02-27`, retrieved 2026-10-26)
- Results first posted: 2023-02-27 (ClinicalTrials.gov record NCT03715998, source copy `cardio:ctgov-nct03715998-2023-02-27`, retrieved 2026-10-26)
- Countries: France; Germany; Hungary; Poland; Slovakia; Spain; United Kingdom (ClinicalTrials.gov record NCT03715998, source copy `cardio:ctgov-nct03715998-2023-02-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03715998-2023-02-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction
- Acronym: QUORUM
- Condition: Myocardial Infarction
- Intervention (Drug): Ramipril
- Intervention (Drug): Firibastat
- Lead sponsor: Quantum Genomics SA
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Ramipril (`cardio:ramipril`)
- Registry lists this organization as the lead sponsor: Quantum Genomics SA (`cardio:org-quantum-genomics-sa`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 Study (`cardio:pubmed-36757536`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 91b2903fcf474a456922bc080a540f71c89192cb12b52e0c00c596325c38e1fd
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
